Group 1 - On January 16, Madi Technology's stock fell by 3.38%, with a trading volume of 331 million yuan. The margin trading data showed a financing buy amount of 31.92 million yuan and a financing repayment of 36.84 million yuan, resulting in a net financing buy of -4.92 million yuan. As of January 16, the total margin trading balance was 262 million yuan [1] - The financing buy on January 16 was 31.92 million yuan, with a current financing balance of 262 million yuan, accounting for 5.44% of the circulating market value. This financing balance is above the 60th percentile level over the past year, indicating a high position [1] - In terms of securities lending, on January 16, Madi Technology had no shares repaid and sold 900 shares, amounting to 14,200 yuan at the closing price. The remaining securities lending volume was 10,100 shares, with a balance of 158,900 yuan, exceeding the 90th percentile level over the past year, indicating a high position [1] Group 2 - As of September 30, Madi Technology had 38,900 shareholders, an increase of 7.17% from the previous period. The average circulating shares per person were 7,864, a decrease of 6.69% [2] - For the period from January to September 2025, Madi Technology achieved an operating income of 22.3 million yuan, a year-on-year decrease of 38.13%. However, the net profit attributable to the parent company was 34.27 million yuan, reflecting a year-on-year growth of 120.49% [2] - In terms of dividends, Madi Technology has distributed a total of 71.36 million yuan since its A-share listing, with no dividends paid in the last three years [3]

Group 1 - The core viewpoint of the news is that Meditech experienced a decline in stock price and trading volume, with significant changes in financing and stockholder metrics [1][2]. - On January 6, Meditech's stock fell by 0.65%, with a trading volume of 274 million yuan. The financing buy-in amount was 21.23 million yuan, while the financing repayment was 32.91 million yuan, resulting in a net financing buy of -11.68 million yuan [1]. - As of January 6, the total balance of margin trading for Meditech was 268 million yuan, with a financing balance of 267 million yuan, accounting for 5.71% of the circulating market value, indicating a high level compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Meditech increased to 38,900, a rise of 7.17%, while the average circulating shares per person decreased by 6.69% to 7,864 shares [2]. - For the period from January to September 2025, Meditech reported operating revenue of 22.3 million yuan, a year-on-year decrease of 38.13%, while the net profit attributable to the parent company was 34.27 million yuan, showing a year-on-year increase of 120.49% [2]. - Meditech has cumulatively distributed dividends of 71.36 million yuan since its A-share listing, with no dividends distributed in the last three years [3].

Core Viewpoint - The stock of Madi Technology has experienced fluctuations, with a notable decline of 5.19% on December 29, 2023, despite a year-to-date increase of 50.97% [1] Group 1: Stock Performance - As of December 29, 2023, Madi Technology's stock price is 15.52 yuan per share, with a market capitalization of 4.754 billion yuan [1] - The stock has seen a net outflow of 1.3398 million yuan in principal funds, with significant buying and selling activity from large orders [1] - Over the past five trading days, the stock has decreased by 1.96%, and over the past 20 days, it has decreased by 0.70%, while it has increased by 6.30% over the past 60 days [1] Group 2: Company Overview - Madi Technology, established on August 14, 2009, and listed on December 8, 2016, specializes in clinical medical management information systems (CIS) and overall solutions for clinical informationization [2] - The company's revenue composition includes self-developed software (40.39%), operation and maintenance services (31.55%), medical services (21.12%), overall solutions (4.60%), purchased software and hardware (1.95%), and others (0.40%) [2] - As of September 30, 2023, the number of shareholders has increased by 7.17% to 38,900, with an average of 7,864 circulating shares per person, a decrease of 6.69% [2] Group 3: Financial Performance - For the period from January to September 2023, Madi Technology reported a revenue of 223 million yuan, a year-on-year decrease of 38.13%, while the net profit attributable to the parent company was 34.27 million yuan, reflecting a year-on-year increase of 120.49% [2] - The company has distributed a total of 71.36 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]

Group 1 - The core viewpoint of the news is that Madi Technology has experienced fluctuations in its stock performance and financing activities, indicating a mixed financial outlook [1][2]. - As of December 18, Madi Technology's stock price decreased by 0.26%, with a trading volume of 134 million yuan. The net financing buy was negative at -3.92 million yuan, with a total financing and margin balance of 273 million yuan [1]. - The financing balance of Madi Technology is 273 million yuan, accounting for 5.90% of its market capitalization, which is above the 70th percentile of the past year, indicating a high level of financing activity [1]. - On the short-selling side, Madi Technology had no shares repaid on December 18, with 300 shares sold short, resulting in a short-selling amount of 4,524 yuan. The short-selling balance is 13,600 yuan, exceeding the 90th percentile of the past year [1]. Group 2 - As of September 30, Madi Technology had 38,900 shareholders, an increase of 7.17% from the previous period, while the average circulating shares per person decreased by 6.69% to 7,864 shares [2]. - For the period from January to September 2025, Madi Technology reported operating revenue of 22.3 million yuan, a year-on-year decrease of 38.13%, while the net profit attributable to the parent company was 34.27 million yuan, showing a year-on-year increase of 120.49% [2]. - Madi Technology has distributed a total of 71.36 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3].

Company Overview - Suzhou Medisun Medical Technology Co., Ltd. was established on August 14, 2009, and listed on December 8, 2016. The company specializes in providing Clinical Information Management System (CIS) software and overall solutions for clinical informationization [2] - The revenue composition of the company includes self-developed software (40.39%), operation and maintenance services (31.55%), medical services (21.12%), overall solutions (4.60%), purchased software and hardware (1.95%), and others (0.40%) [2] Financial Performance - For the first half of 2025, the company achieved operating revenue of 135 million yuan, a year-on-year decrease of 47.24%. However, the net profit attributable to the parent company was 28.33 million yuan, reflecting a year-on-year increase of 137.11% [2] - Since its A-share listing, the company has distributed a total of 71.36 million yuan in dividends, with no dividends distributed in the last three years [3] Stock Market Activity - As of October 24, the company's stock price increased by 2.01%, reaching 15.26 yuan per share, with a total market capitalization of 4.674 billion yuan [1] - The stock has seen a year-to-date increase of 48.44%, with a 4.59% rise over the last five trading days and a 3.11% increase over the last 20 days, although it has decreased by 6.09% over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" eight times this year, with the most recent appearance on March 10, where it recorded a net buy of 31.16 million yuan [1] Shareholder Information - As of June 30, the number of shareholders was 36,300, a decrease of 24.87% from the previous period, while the average circulating shares per person increased by 33.09% to 8,429 shares [2] - Among the top ten circulating shareholders, Penghua Carbon Neutral Theme Mixed A (016530) is the eighth largest shareholder, holding 2.19 million shares as a new shareholder [3]

Company Overview - Madi Technology's stock price increased by 2.18% on September 25, reaching 14.97 CNY per share, with a trading volume of 1.08 billion CNY and a turnover rate of 2.38%, resulting in a total market capitalization of 45.85 billion CNY [1] - The company has seen a year-to-date stock price increase of 45.62%, with a 1.15% rise over the last five trading days, a 0.34% increase over the last 20 days, and a 6.96% decline over the last 60 days [1] - Madi Technology has appeared on the "Dragon and Tiger List" eight times this year, with the most recent appearance on March 10, where it recorded a net purchase of 31.59 million CNY [1] Financial Performance - For the first half of 2025, Madi Technology reported a revenue of 135 million CNY, a year-on-year decrease of 47.24%, while the net profit attributable to shareholders was 28.33 million CNY, reflecting a year-on-year increase of 137.11% [2] - The company has distributed a total of 71.36 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3] Shareholder Information - As of June 30, 2025, Madi Technology had 36,300 shareholders, a decrease of 24.87% from the previous period, with an average of 8,429 circulating shares per shareholder, an increase of 33.09% [2] - Among the top ten circulating shareholders, Penghua Carbon Neutral Theme Mixed A (016530) is the eighth largest shareholder, holding 2.19 million shares as a new investor [3] Industry Classification - Madi Technology is classified under the computer software development industry, specifically in vertical application software, and is associated with concepts such as Internet healthcare, assisted reproduction, smart healthcare, small-cap stocks, and private hospitals [2]

Group 1 - The core viewpoint of the news is that Madi Technology's stock has shown significant fluctuations, with a year-to-date increase of 40.56% but a recent decline over the past few trading days [1] - As of September 24, Madi Technology's stock price was 14.45 CNY per share, with a market capitalization of 4.426 billion CNY [1] - The company has seen a net inflow of main funds amounting to 3.1634 million CNY, with large orders accounting for 19.67% of total buying [1] Group 2 - Madi Technology operates in the software development sector, specifically in vertical application software, and is involved in concepts such as Internet healthcare and smart medical services [2] - For the first half of 2025, Madi Technology reported a revenue of 135 million CNY, a year-on-year decrease of 47.24%, while net profit attributable to shareholders increased by 137.11% to 28.3275 million CNY [2] - The company has not distributed any dividends in the last three years, with a total payout of 71.3567 million CNY since its A-share listing [3] Group 3 - As of June 30, 2025, Madi Technology had 36,300 shareholders, a decrease of 24.87%, while the average number of circulating shares per person increased by 33.09% to 8,429 shares [2] - Among the top ten circulating shareholders, Penghua Carbon Neutral Theme Mixed A is the eighth largest, holding 2.1936 million shares as a new shareholder [3]

Company Overview - Madi Technology closed at 15.44 yuan, up 2.93%, with a latest price-to-book ratio of 5.75 and a total market capitalization of 4.729 billion yuan [1] - As of the first quarter of 2025, there is one institutional holder of Madi Technology, holding a total of 49.2201 million shares valued at 0.637 billion yuan [1] Business Operations - Suzhou Madi Technology Co., Ltd. specializes in providing Clinical Information System (CIS) application software and overall solutions for clinical information management [1] - The company's main products include self-developed software, comprehensive solutions, purchased software and hardware, operational and technical services, medical service income, and photovoltaic battery cells [1] Financial Performance - For the first quarter of 2025, Madi Technology reported operating revenue of 63.34 million yuan, a year-on-year decrease of 43.13% [1] - The net profit for the same period was 23.5959 million yuan, showing a year-on-year increase of 138.55% [1] - The sales gross margin stood at 66.10% [1] Industry Comparison - Madi Technology's price-to-earnings (P/E) ratio (TTM) is -17.79, while the industry average is 113.36 [2] - The industry median P/E ratio is 20.17, indicating that Madi Technology's valuation is significantly lower than the industry average [2] - The total market capitalization of Madi Technology is 4.729 billion yuan, compared to the industry average of 11.359 billion yuan [2]